DLL4-expressing cells and vaccine using the same
Abstract:
Methods are provided for generating DLL4-expressing immune cells. The invention also includes cellular compositions of dendritic and T cells produced by these methods. The immune cells of the invention can be used widely as components in many diagnostic and therapeutic systems, including improved vaccines to reduce the risk of graft versus host disease.
Information query
Patent Agency Ranking
0/0